ImpaCT_PF
Research type
Research Study
Full title
A multi-center, real-world exploratory cohort study to evaluate cough frequency, severity, and impact on quality of life in patients with non-idiopathic pulmonary fibrosis interstitial lung disease
IRAS ID
302791
Contact name
Simon Hart
Contact email
Sponsor organisation
SCS Boehringer Ingelheim Comm.V
Duration of Study in the UK
1 years, 1 months, 31 days
Research summary
Research Summary-
In patients who have non-IPF ILD, breathing (lung function) will get worse over time and there is increased shortness of breath. Persistent cough may be an important symptom.
The purpose of this study is to evaluate cough and its impact on quality of life.
This study aims to evaluate the frequency of cough, its severity and impact on quality of patient lives (as assessed by patients themselves), and to measure coughing fits during day and night within patients with non-IPF ILD. This will help to expand the understanding of the disease and its symptoms.
This exploratory study does not impact the treatment the participant may receive for your disease.
We estimate that approximately 20 people will participate in this study in United Kingdom(UK) and up to approximately 120 patients worldwide.REC name
Yorkshire & The Humber - Bradford Leeds Research Ethics Committee
REC reference
22/YH/0014
Date of REC Opinion
19 Jul 2022
REC opinion
Further Information Favourable Opinion